{"id":11321,"date":"2026-11-19T15:39:58","date_gmt":"2026-11-19T20:39:58","guid":{"rendered":"https:\/\/www.inflation.us\/news\/?p=11321"},"modified":"2026-11-19T15:39:59","modified_gmt":"2026-11-19T20:39:59","slug":"brainwashed-americans-enriching-best-friend-of-sbf","status":"publish","type":"post","link":"https:\/\/www.inflation.us\/news\/articles\/brainwashed-americans-enriching-best-friend-of-sbf\/","title":{"rendered":"Brainwashed Americans Enriching Best Friend of SBF"},"content":{"rendered":"\n<div style=\"width:100%; max-width:650px; margin:0 auto; padding:0 10px; box-sizing:border-box; font-family:Arial,Helvetica,sans-serif; font-size:14px; line-height:1.65; color:#333333; -webkit-text-size-adjust:100%; -ms-text-size-adjust:100%; text-size-adjust:100%;\">\n<p style=\"margin:0 0 18px 0; padding:0;\">Even if <strong>99% of all <span style=\"color:#27ae60;\">publicly traded<\/span> companies <span style=\"color:#e74c3c;\">decline<\/span> in value<\/strong> over the next twelve months, <strong>Medicure (TSXV: MPH)<\/strong> will <span style=\"color:#27ae60;\"><strong>rise significantly<\/strong><\/span> no matter what. It doesn&#8217;t matter if <strong><span style=\"color:#f1c40f;\">gold stocks<\/span> <span style=\"color:#e74c3c;\">crash by 90%<\/span><\/strong> from current levels. It <span style=\"color:#e74c3c;\"><strong>doesn&#8217;t matter<\/strong><\/span> if <strong>AI stocks <span style=\"color:#e74c3c;\">crash by 90%<\/span><\/strong> from current levels. All that matters is that <strong>Medicure <span style=\"color:#27ae60;\">gets<\/span> FDA approval<\/strong> for <strong>MC-1<\/strong> and it will be <strong>$30 per share<\/strong> because of the value of the <strong>Priority Review Voucher <\/strong>it will <span style=\"color:#27ae60;\"><strong>receive<\/strong><\/span> due to its <strong>Rare Pediatric Disease<\/strong> designation. This is the only <strong>biotech stock<\/strong> that <strong>NIA&#8217;s President<\/strong> has ever <span style=\"color:#27ae60;\"><strong>invested<\/strong><\/span> in, period. Our last <strong>biotech stock suggestion<\/strong> with <strong>Phase 3 trials <span style=\"color:#27ae60;\">gained by 276%<\/span><\/strong> within 54 days of our suggestion and achieved total <span style=\"color:#27ae60;\"><strong>gains of 3,580%<\/strong><\/span> from its low to high. <strong>MPH<\/strong> has close to a <span style=\"color:#27ae60;\"><strong>100% chance<\/strong><\/span> of being <strong>$30+ per share<\/strong> by this time next year. Maybe there is a <span style=\"color:#e74c3c;\"><strong>1% chance<\/strong><\/span> we are <span style=\"color:#e74c3c;\"><strong>wrong<\/strong><\/span> about them getting <strong>FDA approval<\/strong> but as long as you <span style=\"color:#27ae60;\"><strong>invest <\/strong><\/span><span style=\"color:#2980b9;\"><strong>early<\/strong><\/span> you can then sell at <strong>$20 per share<\/strong> <strong><span style=\"color:#2980b9;\">before<\/span> <\/strong>the<strong> final trial data<\/strong> <span style=\"color:#27ae60;\"><strong>gets released<\/strong><\/span> in September 2027.<\/p>\n\n<p style=\"margin:0 0 18px 0; padding:0;\">Let&#8217;s say <strong>MPH <span style=\"color:#27ae60;\">hits<\/span> $20 per share<\/strong> in <strong>May 2027<\/strong> and in <strong>September 2027<\/strong> it turns out they <span style=\"color:#e74c3c;\"><strong>picked the wrong babies<\/strong><\/span> for the trial that <span style=\"color:#e74c3c;\"><strong>didn&#8217;t<\/strong><\/span> even have <strong>PNPO deficiency<\/strong> their <span style=\"color:#e74c3c;\"><strong>seizures<\/strong><\/span> were being caused by something totally different, and <strong>MC-1<\/strong> didn&#8217;t help. <strong>MPH<\/strong> would obviously <span style=\"color:#e74c3c;\"><strong>crash<\/strong><\/span> from <strong>$20 <span style=\"color:#e74c3c;\">down to<\/span> $3<\/strong> instead of going to <strong>$30+ per share<\/strong>&#8230; and we will still consider it to be a <span style=\"color:#27ae60;\"><strong>huge winner<\/strong><\/span>, and it <span style=\"color:#e74c3c;\"><strong>won&#8217;t be our fault<\/strong><\/span> if you <span style=\"color:#e74c3c;\"><strong>don&#8217;t sell<\/strong><\/span> at <strong>$20 per share<\/strong> for a <span style=\"color:#27ae60;\"><strong>huge profit<\/strong><\/span>.<\/p>\n\n<p style=\"margin:0 0 18px 0; padding:0;\">When we said<strong> Trio-Tech International (TRT)<\/strong> had a <span style=\"color:#27ae60;\"><strong>100% chance of going up<\/strong><\/span> just like we are saying today about <strong>Medicure (TSXV: MPH)<\/strong>, <strong>TRT <span style=\"color:#27ae60;\">rose<\/span><\/strong> from our <strong>$3 suggestion price <span style=\"color:#27ae60;\">up to a high<\/span><\/strong> of <strong>$21.38 per share<\/strong> for a <span style=\"color:#27ae60;\"><strong>gain of 612.67%<\/strong><\/span>. It is <span style=\"color:#e74c3c;\"><strong>not our fault<\/strong><\/span> if you <span style=\"color:#e74c3c;\"><strong>didn&#8217;t sell<\/strong><\/span>! Even worse, if you <span style=\"color:#27ae60;\"><strong>bought<\/strong><\/span> at <strong>$20+ per share<\/strong> for the first time you <span style=\"color:#e74c3c;\"><strong>shouldn&#8217;t<\/strong><\/span> be <span style=\"color:#27ae60;\"><strong>investing<\/strong><\/span>!<\/p>\n\n<p style=\"margin:0 0 18px 0; padding:0;\">The <span style=\"color:#e74c3c;\"><strong>dumbest thing<\/strong><\/span> you can do is <span style=\"color:#2980b9;\"><strong>wait<\/strong><\/span> until <strong>MPH <span style=\"color:#27ae60;\">hits<\/span> $20 per share<\/strong> to <span style=\"color:#27ae60;\"><strong>enter<\/strong><\/span> for the chance of a <span style=\"color:#27ae60;\"><strong>50% one-month gain<\/strong><\/span> in <strong>September 2027<\/strong> (even if <strong>approval odds<\/strong> are <span style=\"color:#27ae60;\"><strong>99%<\/strong><\/span>).<\/p>\n\n<p style=\"margin:0 0 18px 0; padding:0;\">If you <strong><span style=\"color:#e74c3c;\">don&#8217;t<\/span> <span style=\"color:#27ae60;\">invest<\/span><\/strong> into <strong>Medicure<\/strong> there is <span style=\"color:#e74c3c;\"><strong>nothing<\/strong><\/span> we can do to <span style=\"color:#2980b9;\"><strong>help<\/strong><\/span> you. We <span style=\"color:#e74c3c;\"><strong>weren&#8217;t<\/strong><\/span> going to tell anybody else about it at all, but <span style=\"color:#2980b9;\"><strong>liquidity<\/strong><\/span> began to <span style=\"color:#e74c3c;\"><strong>drain<\/strong><\/span> from all <strong><span style=\"color:#f1c40f;\">gold<\/span><\/strong> and <strong>AI stocks<\/strong> due to idiots wanting to buy the <strong>Anthropic IPO<\/strong> to <span style=\"color:#27ae60;\"><strong>enrich<\/strong><\/span> the <span style=\"color:#2980b9;\"><strong>best friend<\/strong><\/span> of <strong>Sam Bankman-Fried<\/strong>. Without the money <strong>SBF <span style=\"color:#e74c3c;\">stole<\/span><\/strong> from <strong>FTX account holders <\/strong>through<strong> Alameda Research<\/strong>, <strong>Anthropic <span style=\"color:#e74c3c;\">wouldn&#8217;t<\/span><\/strong> even exist at all and <strong>everybody&#8217;s lives<\/strong> would be <span style=\"color:#2980b9;\"><strong>better off<\/strong><\/span> with <span style=\"color:#e74c3c;\"><strong>much lower inflation<\/strong><\/span>. We know <strong>Michael Lewis<\/strong> and it <strong><span style=\"color:#e74c3c;\">sickens<\/span><\/strong> us how he continues to <span style=\"color:#2980b9;\"><strong>defend<\/strong><\/span> this <strong>SBF<\/strong> like he should be <span style=\"color:#2980b9;\"><strong>pardoned<\/strong><\/span> because <strong>&#8220;he was right&#8221;<\/strong> and the <strong>Anthropic shares<\/strong> the receiver sold for <span style=\"color:#27ae60;\"><strong>$1.3 billion<\/strong><\/span> would today be worth <span style=\"color:#27ae60;\"><strong>$42.3 billion<\/strong><\/span>.<\/p>\n\n<p style=\"margin:0 0 18px 0; padding:0;\">People investing into this <strong>Anthropic <span style=\"color:#e74c3c;\">scam<\/span><\/strong> make us <span style=\"color:#e74c3c;\"><strong>sick<\/strong><\/span>&#8230; this is <strong><span style=\"color:#e74c3c;\">not<\/span><\/strong> a <strong>conscious being<\/strong> this is a commoditized <strong>LLM<\/strong> with thousands of competitors. <strong>Claude&#8217;s top models<\/strong> might be <span style=\"color:#27ae60;\"><strong>slightly better<\/strong><\/span> at <strong>coding<\/strong> than <strong>DeepSeek<\/strong> at the moment, but <strong>DeepSeek<\/strong> is <span style=\"color:#2980b9;\"><strong>equal<\/strong><\/span> or <span style=\"color:#27ae60;\"><strong>superior<\/strong><\/span> at <strong>99%<\/strong> of <strong>normal tasks<\/strong> for <strong><span style=\"color:#e74c3c;\">90% less<\/span> money<\/strong>. If you are <span style=\"color:#2980b9;\"><strong>relying<\/strong><\/span> on <strong>Claude<\/strong> to do all of your <strong>coding <\/strong>maybe you should get into a <span style=\"color:#e74c3c;\"><strong>different<\/strong><\/span> <strong>line of work<\/strong>. Maybe this has something to do with <strong>dozens of computer systems <span style=\"color:#e74c3c;\">randomly crashing<\/span><\/strong> in recent weeks.<\/p>\n\n<p style=\"margin:0 0 18px 0; padding:0;\">In one single day today <strong>Anthropic <span style=\"color:#27ae60;\">raised significantly more<\/span><\/strong> money than the <strong>total market cap<\/strong> of <strong><span style=\"color:#27ae60;\">all<\/span> TSX Venture Exchange natural resource companies<\/strong> <strong><span style=\"color:#2980b9;\">combined<\/span><\/strong>! All of this money is already <span style=\"color:#2980b9;\"><strong>earmarked<\/strong><\/span> to <strong><span style=\"color:#27ae60;\">purchase new<\/span> Nvidia GPUs<\/strong>, which are already <span style=\"color:#2980b9;\"><strong>fully priced<\/strong><\/span> into <strong>Nvidia&#8217;s share price<\/strong> and the <strong>share prices<\/strong> of hundreds of other <strong><span style=\"color:#e74c3c;\">extremely overvalued<\/span> AI companies<\/strong>. For <strong>Nvidia<\/strong> to <span style=\"color:#2980b9;\"><strong>continue<\/strong><\/span><span style=\"color:#27ae60;\"><strong> growing<\/strong><\/span> past 2027,<strong> Anthropic<\/strong> will need to continue <span style=\"color:#e74c3c;\"><strong>severely diluting<\/strong><\/span> or <span style=\"color:#e74c3c;\"><strong>issuing massive amounts of debt<\/strong><\/span>.<\/p>\n\n<p style=\"margin:0 0 18px 0; padding:0;\"><strong><span style=\"color:#e74c3c;\">Without<\/span><\/strong> <strong><span style=\"color:#27ae60;\">massive new discoveries<\/span><\/strong> of <strong>natural resources<\/strong>, it <span style=\"color:#e74c3c;\"><strong>won&#8217;t<\/strong><\/span> be possible for these <strong>Nvidia GPUs<\/strong> to even be <span style=\"color:#2980b9;\"><strong>hooked up<\/strong><\/span>. We will be <span style=\"color:#2980b9;\"><strong>waiting<\/strong><\/span> until <strong>mid-December<\/strong> to <strong><span style=\"color:#27ae60;\">accumulate<\/span> cheap shares<\/strong> of the <strong><span style=\"color:#27ae60;\">highest quality<\/span> natural resource companies<\/strong>. NIA <span style=\"color:#2980b9;\"><strong>predicted<\/strong><\/span> two weeks ago on November 4th, <strong>&#8220;Anybody who <span style=\"color:#27ae60;\">bought<\/span> in January 2026 and wants to <span style=\"color:#e74c3c;\">exit<\/span> TSX Venture natural resource stocks at a <span style=\"color:#e74c3c;\">loss<\/span> will <span style=\"color:#e74c3c;\">sell<\/span> within the next six weeks and all <span style=\"color:#e74c3c;\">selling pressure<\/span> will be <span style=\"color:#e74c3c;\">gone<\/span> by the final week of December. The final week of December is historically the <span style=\"color:#27ae60;\">largest up<\/span> week of the year for TSX Venture stocks, but we are likely to see a <span style=\"color:#2980b9;\">more gradual<\/span> <span style=\"color:#27ae60;\">move up<\/span> in January (<span style=\"color:#e74c3c;\">not<\/span> a <span style=\"color:#27ae60;\">large spike up<\/span>) that will continue into February\/March mainly from a <span style=\"color:#e74c3c;\">lack<\/span> of <span style=\"color:#e74c3c;\">selling<\/span> not necessarily a <span style=\"color:#2980b9;\">rush<\/span> to <span style=\"color:#27ae60;\">buy<\/span>.&#8221;<\/strong><\/p>\n\n<p style=\"margin:0 0 18px 0; padding:0;\">When <span style=\"color:#f1c40f;\"><strong>gold<\/strong><\/span> was <span style=\"color:#f1c40f;\"><strong>$4,688 per oz<\/strong><\/span> and <strong>Peter Schiff <span style=\"color:#27ae60;\">predicted<\/span> <span style=\"color:#f1c40f;\">$6,500 per oz<\/span><\/strong> before year-end, <strong>NIA <span style=\"color:#27ae60;\">predicted<\/span><\/strong> a <span style=\"color:#e74c3c;\"><strong>dip<\/strong><\/span> to <span style=\"color:#f1c40f;\"><strong>$3,800 per oz<\/strong><\/span> and <strong>NIA&#8217;s prediction <span style=\"color:#2980b9;\">came true<\/span><\/strong> as usual.<\/p>\n\n<div style=\"margin:22px 0 0; padding:12px 0 0; border-top:1px solid #dddddd; font-family:Arial,Helvetica,sans-serif; font-size:11px; line-height:1.55; color:#777777; font-style:italic;\">Past performance is not indicative of future results. NIA is not an investment advisor and does not provide investment advice. Always do your own research and make your own investment decisions. NIA&#8217;s President has purchased 87,000 shares of MPH and intends to buy more shares. This communication is for informational and educational purposes only.<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Even if 99% of all publicly traded companies decline in value over the next twelve months, Medicure (TSXV: MPH) will rise significantly no matter what. It doesn&#8217;t matter if gold stocks crash by 90% from current levels. It doesn&#8217;t matter if AI stocks crash by 90% from current levels. All that matters is that Medicure [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":11322,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[5],"tags":[426,365,104,9,414,78,26,8,127],"class_list":["post-11321","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-articles","tag-ant","tag-biotech","tag-crypto","tag-gold","tag-mph","tag-nvda","tag-politics","tag-technology","tag-trt"],"_links":{"self":[{"href":"https:\/\/www.inflation.us\/news\/wp-json\/wp\/v2\/posts\/11321","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.inflation.us\/news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.inflation.us\/news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.inflation.us\/news\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.inflation.us\/news\/wp-json\/wp\/v2\/comments?post=11321"}],"version-history":[{"count":1,"href":"https:\/\/www.inflation.us\/news\/wp-json\/wp\/v2\/posts\/11321\/revisions"}],"predecessor-version":[{"id":11323,"href":"https:\/\/www.inflation.us\/news\/wp-json\/wp\/v2\/posts\/11321\/revisions\/11323"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.inflation.us\/news\/wp-json\/wp\/v2\/media\/11322"}],"wp:attachment":[{"href":"https:\/\/www.inflation.us\/news\/wp-json\/wp\/v2\/media?parent=11321"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.inflation.us\/news\/wp-json\/wp\/v2\/categories?post=11321"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.inflation.us\/news\/wp-json\/wp\/v2\/tags?post=11321"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}